Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.8, 2002-08, pp. : 513-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An open‐label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 256-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

By Noveck Robert J.

Clinical Pharmacokinetics, Vol. 46, Iss. 6, 2007-01 ,pp. : 525-534

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency

By Chevalier P.

Clinical Pharmacokinetics, Vol. 39, Iss. 1, 2000-07 ,pp. : 77-84

Adis International

Access to resources Recommend Favorite

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

By Spigset Olav Hägg Staffan Stegmayr Bernd Dahlqvist Rune

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 699-703

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

By Weil Angelika

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite